Table 5.
Any Excess Dosing (>0%) | Overall Drug (n=1681) | |
---|---|---|
Covariates | Odds Ratio (95% CI) | P value |
Excess dosing | 1.34 (0.91 – 1.98) | 0.14 |
Female vs. Male | 1.28 (0.83 – 2.00) | 0.27 |
Diabetes mellitus | 1.41 (0.93 – 2.13) | 0.11 |
Percutaneous coronary intervention urgency | 1.07 (0.50 – 2.33) | 0.86 |
Systolic blood pressure | 2.16 (1.21 – 3.86) | 0.01 |
Prior peripheral arterial disease | 2.17 (0.83 – 5.63) | 0.11 |
ST-elevation Myocardial Infarctiona | 1.92 (1.19 – 3.10) | 0.01 |
Aspirin + prasugrelb | 0.42 (0.19 – 0.92) | 0.03 |
eGFR (decrease of 10 points) | 1.11 (1.03 – 1.21) | 0.01 |
Age (increase of 5 years) | 1.03 (0.87 – 1.23) | 0.70 |
Weight (decrease of 5 kg) | 1.00 (0.96 – 1.05) | 0.98 |
Reference group for this variable is Non ST-elevation Myocardial Infarction
Reference group for this variable is aspirin + clopidogrel/ticlopidine
Abbreviation: eGFR – Estimated Glomerular Filtration Rate